By Iain Gilbert
Date: Monday 29 Jun 2026
(Sharecast News) - Genus revealed on Monday that non-executive director Celia Baxter had acquired 2,336 ordinary shares in the FTSE 250-listed biotech firm.
Baxter, who joined the board of Genus in November 2025, purchased the shares on Friday at an average price 2,139.51p each, for a total value of £49,979.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news